P-Cresyl Sulfate Is a Valuable Predictor of Clinical Outcomes in Pre-ESRD Patients

Figure 1

Kaplan-Meier curves of time to first clinical events. Patients were divided into two groups (>6.0 mg/L and ≦6.0 mg/L) by medium level of p-cresyl sulfate. (a) All-cause mortality, log rank 𝑃=0.26, (b) cardiovascular event, log rank 𝑃=0.03, and (c) dialysis event, log rank 𝑃<0.01.

(a)

(b)

(c)